These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Nitric oxide donors: novel cancer therapeutics (review). Huerta S; Chilka S; Bonavida B Int J Oncol; 2008 Nov; 33(5):909-27. PubMed ID: 18949354 [TBL] [Abstract][Full Text] [Related]
28. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells. Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253 [TBL] [Abstract][Full Text] [Related]
29. Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. Deininger MH; Wybranietz WA; Graepler FT; Lauer UM; Meyermann R; Schluesener HJ FASEB J; 2003 Jul; 17(10):1267-76. PubMed ID: 12832291 [TBL] [Abstract][Full Text] [Related]
30. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. Gao X; Deeb D; Jiang H; Liu YB; Dulchavsky SA; Gautam SC J Exp Ther Oncol; 2005; 5(1):39-48. PubMed ID: 16416600 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF-beta, dexamethasone, and p53 gene transfer. Rieger J; Ständer M; Löschmann PA; Heneka M; Dichgans J; Klockgether T; Weller M Oncogene; 1998 Nov; 17(18):2323-32. PubMed ID: 9811463 [TBL] [Abstract][Full Text] [Related]
32. Malignant glioma progression and nitric oxide. Lam-Himlin D; Espey MG; Perry G; Smith MA; Castellani RJ Neurochem Int; 2006 Dec; 49(8):764-8. PubMed ID: 16971023 [TBL] [Abstract][Full Text] [Related]
33. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells. Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735 [TBL] [Abstract][Full Text] [Related]
34. Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Xu T; Fan Z; Li W; Dietel B; Wu Y; Beckmann MW; Wrosch JK; Buchfelder M; Eyupoglu IY; Cao Z; Savaskan NE Sci Rep; 2016 Feb; 6():19799. PubMed ID: 26831010 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery. Eroy-Reveles AA; Mascharak PK Future Med Chem; 2009 Nov; 1(8):1497-507. PubMed ID: 21426062 [TBL] [Abstract][Full Text] [Related]
36. Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Zhang T; Guan M; Xu C; Chen Y; Lu Y Life Sci; 2007 Sep; 81(16):1256-63. PubMed ID: 17919663 [TBL] [Abstract][Full Text] [Related]
37. CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo. Vannini E; Mori E; Tantillo E; Schmidt G; Caleo M; Costa M Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800135 [TBL] [Abstract][Full Text] [Related]
38. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. Hoelzinger DB; Demuth T; Berens ME J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532 [TBL] [Abstract][Full Text] [Related]
39. A Cytochrome c-Chlorotoxin Hybrid Protein as a Possible Antiglioma Drug. Delinois LJ; Peón H; Villalobos-Santos JC; Ramírez-Paz J; Miller J; Griebenow KH; Tinoco AD ChemMedChem; 2020 Nov; 15(22):2185-2192. PubMed ID: 32918396 [TBL] [Abstract][Full Text] [Related]
40. Diazeniumdiolated carbamates: a novel class of nitric oxide donors. Nandurdikar RS; Maciag AE; Cao Z; Keefer LK; Saavedra JE Bioorg Med Chem; 2012 Mar; 20(6):2025-9. PubMed ID: 22356735 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]